Hearing Loss Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Children whose nonverbal problem-solving or intelligence scores fall within a typical range (between 77 and 123 on a standard scale)
- Children with normal hearing must have hearing thresholds at or below 20 dB HL across a range of sound frequencies
- Children with hearing loss must have a pure-tone average (a measure of hearing ability) greater than 65 dB HL
Who may not be able to join:
- Children who do not pass a basic vision screening test (requiring at least 20/30 vision)
- Children who have autism, blindness or other eye conditions, cerebral palsy, significant neurological conditions, vision problems that cannot be corrected, or intellectual disability
- Children whose nonverbal problem-solving or intelligence scores fall outside the typical range (above 123 or below 77)
- Children who are currently taking certain medications known to slow eye movement, such as some anti-depressants, sedatives, or vestibular suppressants — the trial site will review each child's current medications as part of the assessment process
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Kristen L Janky, PhD, Father Flanagan's Boys' Home
Phone: 15313556535
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
The Dynamic Visual Acuity Test; Reading Ability; Static Visual Acuity Test
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.